500009 Stock Overview Manufactures, markets, and supplies pharmaceutical products in India and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Ambalal Sarabhai Enterprises Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Ambalal Sarabhai Enterprises Historical stock prices Current Share Price ₹49.36 52 Week High ₹77.70 52 Week Low ₹39.20 Beta -0.070 1 Month Change -14.13% 3 Month Change -12.48% 1 Year Change -16.40% 3 Year Change 26.24% 5 Year Change 151.20% Change since IPO 241.59%
Recent News & Updates
Ambalal Sarabhai Enterprises Limited to Report Q2, 2025 Results on Nov 12, 2024 Nov 05
Investor sentiment improves as stock rises 16% Oct 14
First quarter 2025 earnings released: EPS: ₹0.05 (vs ₹0.64 loss in 1Q 2024) Aug 10
Ambalal Sarabhai Enterprises Limited to Report Q1, 2025 Results on Aug 09, 2024 Aug 02
Investor sentiment improves as stock rises 17% Jul 05
Ambalal Sarabhai Enterprises Limited Approves Appointment of Jinal Shah as Chief Financial Officer, effective July 26, 2024 May 27 See more updates
Ambalal Sarabhai Enterprises Limited to Report Q2, 2025 Results on Nov 12, 2024 Nov 05
Investor sentiment improves as stock rises 16% Oct 14
First quarter 2025 earnings released: EPS: ₹0.05 (vs ₹0.64 loss in 1Q 2024) Aug 10
Ambalal Sarabhai Enterprises Limited to Report Q1, 2025 Results on Aug 09, 2024 Aug 02
Investor sentiment improves as stock rises 17% Jul 05
Ambalal Sarabhai Enterprises Limited Approves Appointment of Jinal Shah as Chief Financial Officer, effective July 26, 2024 May 27
Ambalal Sarabhai Enterprises Limited, Annual General Meeting, Jun 29, 2024 May 26
Full year 2024 earnings released: EPS: ₹0.74 (vs ₹1.45 in FY 2023) May 25
Ambalal Sarabhai Enterprises Limited Approves Appointment of Jinal Shah as Chief Financial Officer, effective July 26, 2024 May 25
Ambalal Sarabhai Enterprises Limited to Report Q4, 2024 Results on May 24, 2024 May 18
Ambalal Sarabhai Enterprises Limited Announces Change in Directorate, Effective 1st April, 2024 Mar 30
Third quarter 2024 earnings released: EPS: ₹0.15 (vs ₹0.40 in 3Q 2023) Feb 14
Ambalal Sarabhai Enterprises Limited to Report Q3, 2024 Results on Feb 13, 2024 Feb 06
New minor risk - Share price stability Jan 15
Investor sentiment improves as stock rises 21% Nov 17
Ambalal Sarabhai Enterprises Limited to Report Q2, 2024 Results on Nov 07, 2023 Oct 31
Ambalal Sarabhai Enterprises Limited Appoints Disha Mahesh Punjani as Company Secretary and Compliance Officer Oct 18
Investor sentiment improves as stock rises 16% Oct 03
Ambalal Sarabhai Enterprises Limited Announces Resignation of Damodar H. Sejpal as Company Secretary and Compliance Officer, Effective October 8, 2023 Sep 29 Ambalal Sarabhai Enterprises Limited Appoints Mr. Brijesh Khandelwal as Additional Independent Director Sep 09
Insufficient new directors Sep 01
Ambalal Sarabhai Enterprises Limited, Annual General Meeting, Sep 28, 2023 Aug 25
New major risk - Share price stability Aug 24
Investor sentiment improves as stock rises 20% Aug 24
First quarter 2024 earnings released: ₹0.64 loss per share (vs ₹0.21 profit in 1Q 2023) Aug 11
Ambalal Sarabhai Enterprises Limited to Report Q1, 2024 Results on Aug 10, 2023 Aug 05
New minor risk - Share price stability Jun 14
Investor sentiment improves as stock rises 23% Jun 12
Full year 2023 earnings released: EPS: ₹1.45 (vs ₹6.16 in FY 2022) Jun 04
Ambalal Sarabhai Enterprises Limited to Report Q4, 2023 Results on May 30, 2023 May 25
Third quarter 2023 earnings released: EPS: ₹0.40 (vs ₹0.46 in 3Q 2022) Feb 12
Ambalal Sarabhai Enterprises Limited to Report Q3, 2023 Results on Feb 10, 2023 Feb 05
Second quarter 2023 earnings released: EPS: ₹0.13 (vs ₹1.24 in 2Q 2022) Nov 13
Ambalal Sarabhai Enterprises Limited to Report Q2, 2023 Results on Nov 09, 2022 Nov 05
First quarter 2023 earnings released: EPS: ₹0.21 (vs ₹3.47 in 1Q 2022) Aug 12
Ambalal Sarabhai Enterprises Limited, Annual General Meeting, Sep 21, 2022 Aug 12
Ambalal Sarabhai Enterprises Limited to Report Q1, 2023 Results on Aug 10, 2022 Aug 06
Full year 2022 earnings released: EPS: ₹6.16 (vs ₹3.83 in FY 2021) May 31
Ambalal Sarabhai Enterprises Limited to Report Q4, 2022 Results on May 26, 2022 May 19
Less than half of directors are independent Apr 27
Investor sentiment improved over the past week Apr 04
Investor sentiment deteriorated over the past week Feb 24
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Feb 16
Investor sentiment improved over the past week Jan 21
Less than half of directors are independent Jan 13
Investor sentiment improved over the past week Dec 27
Second quarter 2022 earnings released: EPS ₹1.24 (vs ₹1.41 in 2Q 2021) Nov 18
First quarter 2022 earnings released: EPS ₹3.47 (vs ₹0.12 in 1Q 2021) Aug 12
Investor sentiment improved over the past week Aug 03
Investor sentiment deteriorated over the past week Jun 11
Full year 2021 earnings released: EPS ₹3.83 (vs ₹1.84 in FY 2020) Jun 06
Investor sentiment improved over the past week May 12
Investor sentiment improved over the past week Apr 24
New 90-day low: ₹19.10 Feb 17
Third quarter 2021 earnings released: EPS ₹0.26 (vs ₹0.06 in 3Q 2020) Feb 15
Ambalal Sarabhai Enterprises Limited to Report Q3, 2021 Results on Feb 12, 2021 Feb 06
New 90-day high: ₹24.45 Jan 04
Investor sentiment improved over the past week Jan 04
Market pulls back on stock over the past week Nov 21
Market bids up stock over the past week Nov 17
Second quarter 2021 earnings released: EPS ₹1.41 Nov 12
Ambalal Sarabhai Enterprises Limited to Report Q2, 2021 Results on Nov 10, 2020 Nov 05
Market pulls back on stock over the past week Oct 21
Market pulls back on stock over the past week Oct 19
Market bids up stock over the past week Oct 12
First quarter earnings released Aug 22
New 90-day high - ₹29.50 Aug 19
Ambalal Sarabhai Enterprises Limited to Report Q1, 2021 Results on Aug 20, 2020 Aug 15
New 90-day high - ₹20.30 Jul 21
Ambalal Sarabhai Enterprises Limited to Report Q4, 2020 Results on Jul 22, 2020 Jul 18 Shareholder Returns 500009 IN Pharmaceuticals IN Market 7D 0.2% -1.3% 0.9% 1Y -16.4% 20.2% 6.8%
See full shareholder returns
Return vs Market: 500009 underperformed the Indian Market which returned 6.8% over the past year.
Price Volatility Is 500009's price volatile compared to industry and market? 500009 volatility 500009 Average Weekly Movement 7.5% Pharmaceuticals Industry Average Movement 6.0% Market Average Movement 6.3% 10% most volatile stocks in IN Market 9.1% 10% least volatile stocks in IN Market 4.3%
Stable Share Price: 500009 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 500009's weekly volatility (7%) has been stable over the past year.
About the Company Ambalal Sarabhai Enterprises Limited, together with its subsidiaries, manufactures, markets, and supplies pharmaceutical products in India and internationally. The company operates through Pharmaceuticals and Electronics segments. It offers products for oncology, infertility, and uro-gynaec areas; generic and veterinary products; antifungal active ingredient products; vitamin C coated products; and analytical, test, and measuring instruments, as well as supplies finished dosage forms and active pharmaceutical ingredients.
Show more Ambalal Sarabhai Enterprises Limited Fundamentals Summary How do Ambalal Sarabhai Enterprises's earnings and revenue compare to its market cap? 500009 fundamental statistics Market cap ₹3.78b Earnings (TTM ) ₹124.35m Revenue (TTM ) ₹1.84b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 500009 income statement (TTM ) Revenue ₹1.84b Cost of Revenue ₹1.03b Gross Profit ₹803.80m Other Expenses ₹679.45m Earnings ₹124.35m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 1.62 Gross Margin 43.78% Net Profit Margin 6.77% Debt/Equity Ratio 35.1%
How did 500009 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/02/01 00:25 End of Day Share Price 2025/01/31 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Ambalal Sarabhai Enterprises Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
